arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Arcturus Therapeutics Holdings Inc.

ARCT

$9.34 ▼ -1.50 (-13.84%) at close

9 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Arcturus Therapeutics Holdings Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $255.8M

Dividend Yield —

Revenue Growth -46.1% ↘

Op. Margin -93.0% ↘

ROIC -28.2% ↗

FCF / Share $-2.72 ↘

Trailing P/E —

Price / Book 1.2x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

9-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$82.03M

↓ -46.1% —

Net Income Profit after all expenses

$-65.78M

↑ +18.7% —

Operating Margin Operating profit as % of sales

-93.0%

↓ -48.0% 2th

FCF / Share Free cash flow per share

$-2.72

↓ -21.6% —

Long-Term Debt Long-term obligations

$40.63M

↑ +165.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Revenue Growth YoY (%)	-46.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-677%)	-8.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-209%)	-19.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-338%)	1566.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+19485%)	29.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+270%)	-54.1% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-776%)	32.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+300%)	—	—
EPS Growth YoY (%)	20.0% Good Good Year-over-year change in earnings per share Optimal: > 10%	-167.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—	—	—	—
Net Income Growth YoY (%)	18.7% Good Good Year-over-year change in net income	-172.3% Weak Weak Year-over-year change in net income	N/M	N/M	-182.3% Weak ↓ Weak Declining Year-over-year change in net income	-177.6% Weak Weak Year-over-year change in net income	-19.3% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-21.6% Weak Weak Year-over-year change in free cash flow	-183.6% Weak Weak Year-over-year change in free cash flow	N/M	N/M	—	—	—	—	—
Revenue CAGR 3Y (%)	-26.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	131.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	159.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	114.8% Excellent Excellent Compound annual revenue growth over 3 years	-7.8% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	53.8% Excellent → Excellent Stable Compound annual revenue growth over 5 years	48.9% Excellent Excellent Compound annual revenue growth over 5 years	60.3% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Operating Margin (%) (%)	-93.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-720%)	-62.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-519%)	-46.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-413%)	5.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-61%)	—	—	-122.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-918%)	-138.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1023%)	—
Effective Tax Rate (%) (%)	—	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-6.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	12.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—
Profit Margin (%) (%)	-80.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-768%)	-53.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-543%)	-17.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-249%)	4.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-62%)	—	—	-125.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1142%)	-138.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1252%)	—
FCF Margin (%) (%)	-90.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-39.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-12.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	11.8% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-467.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-34.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-141.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	1.13x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	2.60x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.28x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Return on Invested Capital (%)	-28.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-39.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	4.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-59.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-48.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-73.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-28.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	2.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-51.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-49.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-30.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-305%)	-33.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-324%)	-10.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-171%)	3.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-77%)	-89.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-695%)	-18.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-221%)	-100.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-772%)	-159.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1165%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Debt to Equity (x)	—	—	—	—	0.18x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-70%)	0.04x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-94%)	0.60x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	0.73x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+21%)	—
Interest Coverage (x)	—	—	-36.77x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	14.98x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-296.57x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-95.24x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-36.92x Weak Weak Operating income divided by interest expense Optimal: > 5x	-149.39x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-230.91M	$-237.03M	$-292.00M	$-391.88M	$-329.86M	$-447.60M	$-55.90M	$-26.80M	—
Debt / EBITDA (x)	—	—	—	—	-0.20x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.21x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.61x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.45x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Revenue per Share (USD)	$3.00	$5.64	$6.26	$7.79	$0.47	—	—	—	—
Basic EPS, GAAP (USD)	$-2.40	$-3.00	$-1.12	$0.35	$-7.74	—	—	—	—
Free Cash Flow per Share (USD)	$-2.72	$-2.24	$-0.79	$0.92	$-5.26	—	—	—	—
Book Value per Share (USD)	$7.53	$8.93	$10.38	$10.18	$8.65	$15.14	$1.70	$1.27	—
Tangible Book Value per Share (USD)	$7.53	$8.93	$10.38	$10.18	$8.65	$15.14	$1.70	$1.27	—
Basic Weighted Avg Shares (shares)	27.39M	27.00M	26.63M	26.45M	26.32M	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Working Capital (USD)	$205.07M	$240.49M	$304.60M	$276.35M	$279.42M	$418.27M	$52.97M	$29.25M	—
LT Debt (USD)	—	—	—	—	$40.63M	$15.30M	$15.45M	$9.91M	—
Total Equity (USD)	$213.99M	$240.98M	$278.51M	$270.31M	$228.21M	$396.55M	$25.79M	$13.64M	$33.79M

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Sales/Revenue/Turnover (USD)	$82.03M	$152.31M	$166.80M	$206.00M	$12.36M	$9.54M	$20.79M	$15.75M	—
Net Income, GAAP (USD)	$-65.78M	$-80.94M	$-29.73M	$9.35M	$-203.67M	$-72.15M	$-25.99M	$-21.79M	—
Operating Cash Flow (USD)	$-74.27M	$-59.75M	$-18.10M	$31.99M	$-135.04M	$-42.86M	$-6.45M	$-20.76M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 9 years · 35 quarters

Arcturus Therapeutics Holdings Inc.

Analytical Summary

9-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ARCT with peers